Introduction
Kleine-Levin syndrome (KLS), sometimes known as "sleeping beauty syndrome," is an unusual neurological disorder. It causes sudden episodes of extreme sleepiness, often lasting days or even weeks. During these episodes, the person may sleep up to 20 hours a day, waking only to eat or use the toilet. When awake, they might behave differently, showing confusion, irritability, or unusual eating habits. Between episodes, they usually appear completely healthy, which makes diagnosis challenging.1
Doctors still don’t fully understand what causes KLS, but recent research suggests genetics may be involved. In fact, researchers have started to identify particular genes that might increase someone’s risk of developing KLS.2 Knowing more about these genetic factors could help doctors diagnose the condition faster and find better treatments.
Although KLS is rare, affecting around one or two people per million, the condition can have a major impact on the lives of those affected and their families. Episodes typically begin in adolescence, though they can occasionally start in childhood or adulthood, and may continue for several years before gradually improving.1,3 During episodes, individuals often struggle with normal life activities like school, work, or maintaining social relationships.
Because KLS symptoms appear suddenly and unpredictably, families often face significant emotional stress. Getting a clear diagnosis early can relieve some of this uncertainty. Understanding whether genetics contributes to KLS can help provide clearer answers to patients and their families, potentially offering better ways to manage the condition or even predict its occurrence.2
Answering the main question
Researchers believe genetics plays an important role in KLS. Studies have shown that the condition sometimes affects multiple family members, indicating hereditary influences.3 Two genes, in particular, have recently caught scientists' attention: TRANK1 and LMOD3. Variations in these genes have been found in some people with KLS, suggesting these genes might increase the risk of developing the disorder.4,5 Additionally, scientists think KLS could be triggered by environmental factors, such as birth complications or infections, in people who already have certain genetic vulnerabilities.4
Although researchers are making progress, KLS genetics remains complex and poorly understood. Not everyone with the identified gene variations develops KLS, so other factors are also likely involved. Nonetheless, the identification of these genes is an important step forward in understanding the condition.
There’s still much to learn about how exactly genetics influences KLS. To get a clearer picture, let's take a closer look at what scientists have discovered so far and why these findings matter for people affected by the disorder.
Genetic factors identified in KLS
Scientists have been particularly interested in two genes linked with KLS: TRANK1 and LMOD3.
TRANK1 gene
Recent studies have highlighted the TRANK1 gene, which has been previously associated with psychiatric disorders like bipolar disorder and schizophrenia.4 A significant study involving many KLS patients found a strong link between TRANK1 variants and the condition, particularly among people who had experienced birth difficulties such as oxygen deprivation or other complications.4 This suggests that genetic factors alone might not always trigger KLS but could predispose people to the disorder, especially when combined with environmental stressors like difficult births.4
LMOD3 gene
Another gene of interest is LMOD3. In research involving a family with multiple KLS cases, a rare genetic variant in the LMOD3 gene was identified.5 Similar variations in this gene were later discovered in other unrelated people diagnosed with KLS.5 Although these findings are promising, the exact role of LMOD3 in the disorder is still unclear, and scientists are actively researching this link.
Possible mechanisms: the role of the hypothalamus
Genetic variations found in KLS may affect specific brain regions, especially the hypothalamus. This part of the brain helps control sleep, appetite, and emotions; all areas impacted by KLS episodes.1,3 If genetic factors alter the way the hypothalamus works, it might explain why KLS episodes involve unusual sleep patterns and behavioural changes.
One theory is that these genes might affect neurotransmitter chemicals in the brain, such as orexin, which help keep us awake and alert. Orexin deficiencies are already known to cause disorders like narcolepsy, another sleep-related condition, suggesting a similar mechanism could occur in KLS.1
Further research into neurotransmitters and hypothalamic function could offer important clues about the specific biological changes behind KLS symptoms.
Gene-environment interaction
Having certain genes alone doesn't guarantee someone will develop KLS. Instead, researchers believe environmental triggers, such as infections, stress, or birth complications, may also be involved.4 For instance, an individual with genetic vulnerabilities who experiences significant stress or an infection might be more likely to develop KLS episodes. Understanding this interaction could help doctors identify at-risk individuals earlier and provide targeted prevention strategies.
In some cases, infections have been observed to precede the first KLS episodes, supporting the theory that genetics might create vulnerability while environmental triggers initiate the onset.3 This understanding highlights the importance of carefully monitoring at-risk individuals who experience such triggers.
Why does this research matter?
Understanding genetics in KLS can significantly improve how we diagnose and manage the condition. Currently, doctors rely heavily on recognising symptoms, which often leads to delays in diagnosis. Genetic discoveries could lead to earlier identification through testing, allowing quicker treatment and potentially reducing episode severity.
Additionally, understanding genetic factors might lead to personalised treatments, where doctors tailor interventions specifically based on an individual’s genetic profile. Though this research is still in its early stages, it offers promising pathways to better manage this challenging condition.
In the long term, genetic understanding could even lead to preventative approaches, reducing the likelihood of developing KLS in genetically susceptible individuals.
Challenges in living with kleine-levin syndrome
Living with KLS poses significant emotional, social, and educational challenges. Episodes often disrupt school attendance, creating difficulties academically and socially. Young people with KLS may find it hard to maintain friendships and social connections because of their unpredictable episodes. Families frequently express frustration about misunderstandings from teachers, employers, or healthcare professionals who aren't familiar with the disorder.1,3 Greater public awareness and understanding can help reduce stigma and ease these challenges, making life more manageable for affected individuals and their families.
Currently, treatment for KLS mostly involves managing symptoms rather than addressing the root cause. Doctors may prescribe stimulants or medications typically used for mood disorders to help manage sleepiness or behavioural symptoms during episodes.1 However, these treatments don’t prevent episodes entirely and may not work equally well for everyone. A deeper understanding of the genetic factors behind KLS could lead to more targeted treatments that address underlying causes rather than just symptoms.
Future directions in research
Given the complexity of KLS, researchers stress the need for larger studies. Most genetic findings are based on small sample sizes, making it difficult to draw broad conclusions.2,4 Expanding research efforts globally and including more diverse populations could provide stronger, more reliable genetic evidence.
Also, research into how KLS relates to other neurological and psychiatric disorders might reveal important genetic overlaps. Conditions like narcolepsy, bipolar disorder, and schizophrenia share certain symptoms or genetic associations with KLS, suggesting they may involve related pathways or brain mechanisms.4 Understanding these connections could shed light on why some individuals are genetically predisposed to multiple conditions.
The importance of early and accurate diagnosis cannot be overstated. Families often experience relief when a diagnosis finally explains confusing and distressing symptoms. However, delays in diagnosis are common due to low awareness among healthcare providers. Enhancing clinician education about the genetic aspects of KLS could improve diagnostic speed and accuracy, leading to quicker intervention and better long-term outcomes.
Ultimately, ongoing genetic research offers hope for those affected by KLS. Families, doctors, and researchers alike share the goal of reducing the impact of this challenging disorder. Genetic insights may provide clearer explanations for patients, help identify effective treatments, and perhaps eventually lead to prevention strategies for those at highest risk.
Summary
Kleine-Levin syndrome is a rare neurological condition involving repeated episodes of excessive sleep and unusual behaviours. Genetic studies have identified two significant genes, TRANK1 and LMOD3, that may contribute to the disorder. However, genetics alone do not fully explain KLS, and environmental factors such as birth complications or infections likely interact with genetic predispositions. Understanding these complex relationships is key to better diagnosis and treatment.
FAQs
What is kleine-levin syndrome (KLS)?
KLS is a rare neurological condition characterised by episodes of extreme sleepiness and behavioural changes like overeating or confusion.
Is KLS hereditary?
Evidence suggests genetic factors contribute to KLS, but the inheritance patterns aren't fully clear.
Can genetic testing diagnose KLS?
Currently, genetic tests aren't available to diagnose KLS, but future research could change this.
Are there effective treatments for KLS?
No cure exists, but managing symptoms through medication and lifestyle adjustments helps.
Does everyone with KLS gene variations develop symptoms?
No, not everyone with these genetic variations develops KLS, indicating other factors play a role.
References
- Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11(10):918–928. doi:10.1016/S1474-4422(12)70187-4.
- Miglis MG, Guilleminault C. Kleine-Levin syndrome: a review. Nat Sci Sleep. 2014;6:19–26. doi:10.2147/NSS.S44750.
- Lavault S, Golmard JL, Groos E, et al. Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol. 2015;77(3):529–540. doi:10.1002/ana.24372.
- Ambati A, Hillary R, Leu-Semenescu S, et al. Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci. Proc Natl Acad Sci USA. 2021;118(12):e2005753118. doi:10.1073/pnas.2005753118.
- Al Shareef SM, Basit S, Pfister C, et al. Kleine-Levin syndrome is associated with LMOD3 variants. J Sleep Res. 2019;28(6):e12893. doi:10.1111/jsr.12893.

